(2026). Safety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients. Open Access Rheumatology: Research and Reviews.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Safety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients."
Open Access Rheumatology: Research and Reviews 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Safety and Microvascular Effect of Four-Year Aminaphtone Administration in Systemic Sclerosis Patients."
Open Access Rheumatology: Research and Reviews, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.